Web Exclusives

Side effects of certain cancer drugs may be fatal

February 22, 2012

Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.
 

High-definition blood test may become comparable to biopsy

February 21, 2012

An advanced blood test that detects and analyzes circulating tumor cells provides data that could soon compare to that obtained from biopsies.
 

Two approaches recommended to reduce oxaliplatin toxicity during colorectal therapy

February 20, 2012

A review addresses the need to balance the effectiveness of oxaliplatin against its dose-limiting complication of neurotoxicity.
 

Diabetes drug reduces cancer mortality

February 17, 2012

Cancer patients with diabetes who took metformin were found to have a significantly lower overall mortality than cancer patients without diabetes.
 

Vaccine used in early breast cancer shows good immunity response

February 16, 2012

Many women with early breast cancer experienced a sustained immune response after immunization with a vaccine that fights HER2, and this may reduce their risk for more invasive cancer.
 

Exercise improves life after cancer treatment

February 15, 2012

Physical activity was associated with important positive effects on physical functions and quality of life in persons who had completed their treatment for cancer.
 

Membrane temperature offers clue to oral mucositis risk in head and neck cancer

February 14, 2012

Thermal imaging can detect early changes in the temperature of mucosal surfaces that may signal mucositis in persons with head and neck cancer who are receiving chemoradiotherapy.
 

MRI can guide nerve-sparing decision in prostate surgery

February 13, 2012

The use of preoperative magnetic resonance imaging (MRI) can change the surgical plan for men undergoing surgery for prostate cancer.
 

HPV self-testing again shows potential screening value

February 10, 2012

Another study has shown that human papillomavirus (HPV) testing of self-collected cervicovaginal specimens may be an effective way to screen more women for cervical cancer.
 

Oxaliplatin improves survival in general colon cancer population

February 09, 2012

The survival advantage seen with the addition of oxaliplatin to adjuvant 5-FU was just as evident outside of randomized clinical trials as within.
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Side effects of certain cancer drugs may be fatal

February 22, 2012

Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.
 

High-definition blood test may become comparable to biopsy

February 21, 2012

An advanced blood test that detects and analyzes circulating tumor cells provides data that could soon compare to that obtained from biopsies.
 

Two approaches recommended to reduce oxaliplatin toxicity during colorectal therapy

February 20, 2012

A review addresses the need to balance the effectiveness of oxaliplatin against its dose-limiting complication of neurotoxicity.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions